![David Loomis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 334 004 $ au 30/06/2026
Mr. David Loomis is a Chief Accounting Officer & Vice President at Arvinas, Inc. Mr. Loomis was previously employed as a Controller by Biohaven Ltd. and a Controller by Biohaven Pharmaceutical Holding Co. Ltd.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARVINAS, INC. 0,06% | 11/05/2026 | 40 193 ( 0,06% ) | 334 004 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ARVINAS, INC. | Comptroller/Controller/Auditor | 07/11/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Comptroller/Controller/Auditor | 01/11/2022 |
| BIOHAVEN LTD. | Comptroller/Controller/Auditor | 01/11/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Biohaven Ltd.
 Biohaven Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
